Sfoglia per Autore  

Opzioni
Mostrati risultati da 81 a 100 di 107
Titolo Tipologia Data di pubblicazione Autori File
Design, synthesis, and biological activity of urea derivatives as anaplastic lymphoma kinase inhibitors 01 - Articolo su rivista 2011 MOLOGNI, LUCAVILTADI, MICHELAGAMBACORTI PASSERINI, CARLO +
ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells 01 - Articolo su rivista 2011 MAGISTRONI, VERAMOLOGNI, LUCAREDAELLI, SARAPIAZZA, ROCCO GIOVANNIVILTADI, MICHELAGAMBACORTI PASSERINI, CARLO +
Dissection of the RET/ß-catenin interaction in the TPC1 thyroid cancer cell line 01 - Articolo su rivista 2011 TARTARI, CARMEN GIULIADONADONI, CARLAMOLOGNI, LUCAVILLA, ANTONELLOGAMBACORTI PASSERINI, CARLO +
Development of RET kinase inhibitors for targeted cancer therapy 01 - Articolo su rivista 2011 Mologni, L
Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism 01 - Articolo su rivista 2011 MOLOGNI, LUCAGAMBACORTI PASSERINI, CARLO +
Colorectal tumors are effectively eradicated by combined inhibition of {beta}-catenin, KRAS, and the oncogenic transcription factor ITF2 01 - Articolo su rivista 2010 MOLOGNI, LUCACECCON, MONICAPURGANTE, STEFANIAMAGISTRONI, VERAGAMBACORTI PASSERINI, CARLO +
A New BCR-ABL1 Mutation (L248R) Is Highly Resistant to Imatinib, Bosutinib, Nilotinib and Dasatinib, but Can Be Inhibited by AP-24534 and DCC-2036 02 - Intervento a convegno 2010 REDAELLI, SARAMOLOGNI, LUCAROSTAGNO, ROBERTAPIAZZA, ROCCO GIOVANNIVILTADI, MICHELAGAMBACORTI PASSERINI, CARLO +
Inhibitors of the RET tyrosine kinase based on a 2-(alkylsulfanyl)-4-(3- thienyl)nicotinonitrile scaffold 01 - Articolo su rivista 2010 Mologni, LucaGambacorti-Passerini, Carlo +
Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors 01 - Articolo su rivista 2010 MOLOGNI, LUCAROSTAGNO, ROBERTAGAMBACORTI PASSERINI, CARLO +
Role of TMPRSS2/ERG in cellular transformation 02 - Intervento a convegno 2009 MAGISTRONI, VERAMOLOGNI, LUCAGAMBACORTI PASSERINI, CARLO +
Resistance Profile of the BCR/ABL Inhibitor Bosutinib Using a High Throughput random Mutagenesis Assay 02 - Intervento a convegno 2009 PIAZZA, ROCCO GIOVANNIREDAELLI, SARACECCON, MONICAMOLOGNI, LUCAPOGLIANI, ENRICO MARIAGAMBACORTI PASSERINI, CARLO +
Valproic acid enhances bosutinib cytotoxicity in colon cancer cells 01 - Articolo su rivista 2009 MOLOGNI, LUCAMAGISTRONI, VERAPIAZZA, ROCCO GIOVANNIGAMBACORTI PASSERINI, CARLO +
Alfa-carboline inhibitors of npm-alk, ret, and bcr-abl 06 - Brevetti 2008 GAMBACORTI PASSERINI, CARLOMOLOGNI, LUCA +
Characterization of compound 584, an Abl kinase inhibitor with lasting effects 01 - Articolo su rivista 2008 PUTTINI, MIRIAMREDAELLI, SARAMOLOGNI, LUCAGAMBACORTI PASSERINI, CARLO +
BRAF silencing by short hairpin RNA or chemical blockade by PLX4032 leads to different responses in melanoma and thyroid carcinoma cells 01 - Articolo su rivista 2008 MOLOGNI, LUCAGAMBACORTI PASSERINI, CARLO +
Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation 01 - Articolo su rivista 2007 COLUCCIA, ADDOLORATAMOLOGNI, LUCAREDAELLI, SARAGAMBACORTI PASSERINI, CARLO +
Targeted deletion of the muscular dystrophy gene myotilin does not perturb muscle structure or function in mice 01 - Articolo su rivista 2007 Mologni L. +
Oncogenic fusion tyrosine kinases as molecular targets for anti-cancer therapy 01 - Articolo su rivista 2007 TARTARI, CARMEN GIULIAPUTTINI, MIRIAMGAMBACORTI PASSERINI, CARLOMOLOGNI, LUCA +
Sorafenib functions to potently suppress RET tyrosine kinase activity by direct enzymatic inhibition and promoting RET lysosomal degradation independent of proteasomal targeting 01 - Articolo su rivista 2007 MOLOGNI, LUCAGAMBACORTI PASSERINI, CARLO +
Inhibition of RET tyrosine kinase by SU5416 01 - Articolo su rivista 2006 MOLOGNI, LUCAROSTAGNO, ROBERTAPUTTINI, MIRIAMREDAELLI, SARAGAMBACORTI PASSERINI, CARLO +
Mostrati risultati da 81 a 100 di 107
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile